SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fineberg Elena)
 

Search: WFRF:(Fineberg Elena) > (2021) > The tale of TILs in...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

El Bairi, Khalid (author)
Mohamed Premier University
Haynes, Harry R. (author)
Blackley, Elizabeth (author)
show more...
Fineberg, Susan (author)
Shear, Jeffrey (author)
Turner, Sophia (author)
De Freitas, Juliana Ribeiro (author)
Sur, Daniel (author)
Amendola, Luis Claudio (author)
Gharib, Masoumeh (author)
Kallala, Amine (author)
Arun, Indu (author)
Azmoudeh-ardalan, Farid (author)
Fujimoto, Luciana (author)
Sua, Luz F. (author)
Liu, Shi-wei (author)
Lien, Huang-chun (author)
Kirtani, Pawan (author)
Balancin, Marcelo (author)
El Attar, Hicham (author)
Guleria, Prerna (author)
Yang, Wenxian (author)
Shash, Emad (author)
Chen, I-chun (author)
Bautista, Veronica (author)
Do Prado Moura, Jose Fernando (author)
Rapoport, Bernardo L. (author)
Castaneda, Carlos (author)
Spengler, Eunice (author)
Acosta-haab, Gabriela (author)
Frahm, Isabel (author)
Sanchez, Joselyn (author)
Castillo, Miluska (author)
Bouchmaa, Najat (author)
Md Zin, Reena R. (author)
Shui, Ruohong (author)
Onyuma, Timothy (author)
Yang, Wentao (author)
Husain, Zaheed (author)
Willard-gallo, Karen (author)
Coosemans, An (author)
Perez, Edith A. (author)
Provenzano, Elena (author)
Ericsson, Paula Gonzalez (author)
Richardet, Eduardo (author)
Mehrotra, Ravi (author)
Ehinger, Anna (author)
Lund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Patologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Pathology, Lund,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine
Brown, Mark (author)
Lundin, Johan (author)
Loi, Sherene (author)
University of Melbourne
show less...
 (creator_code:org_t)
 
2021-12-01
2021
English.
In: npj Breast Cancer. - : Springer Science and Business Media LLC. - 2374-4677. ; 7:1
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarkers has been under intense examination. Emerging data suggest that TILs are associated with response to both cytotoxic treatments and immunotherapy, particularly for patients with triple-negative BC. In this review from The International Immuno-Oncology Biomarker Working Group, we discuss (a) the biological understanding of TILs, (b) their analytical and clinical validity and efforts toward the clinical utility in BC, and (c) the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate. This information will help set the stage for future approaches to optimize the understanding and clinical utilization of TIL analysis in patients with BC.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

for (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view